StockData
Galectin Therapeutics Inc logo

Galectin Therapeutics Inc (GALT) bonds

GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.91−0.11 (-3.64%)

Close on Nov 17, 2026Market cap $293.47MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Galectin Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Galectin Therapeutics's 10-Q for the period ended Jun 30, 2026

Galectin Therapeutics's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeExpires
December2025 Supplemental LOC$10.00MJun 30, 2027
July2025 Supplemental LOC$10.00MJun 30, 2027
Line Of Credit$60.00MJun 30, 2027
March2025 Supplemental LOC$5.00MJun 30, 2027
November2024 Supplemental LOC$6.00MJun 30, 2027
Supplemental LOC2024$10.00MJun 30, 2027
July2025 Supplemental LOC One$10.00M–
Original LOC December192022$10.00M–
Original LOC December292023$10.00M–
Original LOC June282024$10.00M–
Original LOC June302023$10.00M–
Original LOC March292024$10.00M–
Original LOC March312023$10.00M–

See a number that looks wrong?